AVEO PHARMACEUTICALS, INC. 3/A SEC Filings

Filed On	Filing
13 May 2022	Form 3/A: Ferraresso Michael, Chief Commercial Officer Holds 917 shares of Common Stock
15 Feb 2011	Form 3/A: Bate Kenneth, Director Holds 3,750 shares of Common Stock

Comments